New combo therapy shows promise for diabetes control
NCT ID NCT02622113
First seen Jan 11, 2026 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study looked at the long-term safety and effectiveness of adding canagliflozin to insulin treatment in 139 adults with type 2 diabetes. Participants had already completed a 16-week study and continued taking the combination for an extended period. Researchers tracked side effects, changes in blood sugar levels, and body weight to see if the combination was safe and helpful over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Reserch site
Chugoku, Japan
-
Reserch site
Chūbu, Japan
-
Reserch site
Hokkaido, Japan
-
Reserch site
Kanto, Japan
-
Reserch site
Kinki, Japan
-
Reserch site
Kyushu, Japan
-
Reserch site
Tōhoku, Japan
Conditions
Explore the condition pages connected to this study.